-
UK bans parallel exporting of crucial medicines to help COVID-19 patients
europeanpharmaceuticalreview
March 24, 2020
The UK government has announced that the parallel export of certain essential medicines is banned, to preserve drugs for the treatment of coronavirus patients.
-
COVID-19 Update: Lilly Clinical Trial Activities
contractpharma
March 24, 2020
Will delay most new study starts and pause enrollment in most ongoing studies due to the impact of the COVID-19 pandemic.
-
ICON Launches Coronavirus Observatory
contractpharma
March 24, 2020
Provides real-time updates on COVID-19 vaccine trials and insights into key issues.
-
Gilead halts emergency access to remdesivir in Covid-19 indication
pharmaceutical-technology
March 24, 2020
Gilead Sciences has announced a temporary halt to emergency access to its investigational Covid-19 drug remdesivir due to rising demand.
-
University of Queensland (UQ) receives more funding for Covid-19 vaccine
pharmaceutical-technology
March 24, 2020
The regional government of Queensland and the federal Australian Government have pledged a total of $13m to University of Queensland (UQ) to support the development of its Covid-19 vaccine candidate.
-
Covid-19: Junshi Biosciences, OliX Pharmaceuticals explore drugs
pharmaceutical-technology
March 24, 2020
Junshi Biosciences has partnered with the Institute of Microbiology of the Chinese Academy of Sciences (IMCAS) to co-develop neutralising antibodies for Covid-19 treatment.
-
Novartis, Amneal, Apotex offer hydroxychloroquine for Covid-19
pharmaceutical-technology
March 24, 2020
Novartis is set to donate up to 130 million doses of generic hydroxychloroquine to help fight the Covid-19 coronavirus infection that led to a global pandemic.
-
Cadila Pharma’s Kaka-Ba Hospital and Gujarat Police come together to fight COVID-19
expresspharma
March 24, 2020
Kaka-Ba hospital, the CSR wing of Cadila Pharmaceuticals arranged for the distribution of masks for the protection of all police team in Dholka.
-
Pharma units in AP, Telengana to be exempted from lockdown
expresspharma
March 24, 2020
Government order exempts continuous process units such as pharmaceuticals, APIs etc.
-
CMAB Biopharma Resumes Full-Scale Operation Following the Coronavirus Disease 2019 (COVID-19) Outbreak
prnasia
March 23, 2020
CMAB Biopharma (Suzhou) Inc. ("CMAB"), has continued to monitor the development of the COVID-19 pandemic and has taken proactive measures to primarily protect the health of our employees worldwide.